INTRODUCTION
============

Fecal incontinence is a debilitating condition that affects approximately 2%--20% of the adult population \[[@B1][@B2]\]. It is more common in females, and with advancing age, it is the second most common cause of admission to a nursing home \[[@B3]\]. The most common cause in women is obstetric trauma ([Table 1](#T1){ref-type="table"}) \[[@B1][@B4]\]. Even a normal vaginal delivery is associated with a degree of damage to the nerve supply of the pelvic floor. Although prevention of obstetric trauma altogether is unlikely, obstetricians are becoming aware of the need to recognize injuries at the time of delivery and of the requirement that these injuries be repaired by appropriately skilled personnel \[[@B5]\]. Increased awareness among patients and clinicians that fecal incontinence can be successfully treated in the majority of patients will lead to an increase in referrals \[[@B6][@B7]\]. A neurophysiological assessment of the anorectum includes an assessment of the conduction of the pudendal and spinal nerves, as well as electromyography (EMG) of the sphincter. Anal endosonography (AES) is now superior to EMG in mapping sphincter defects and is so much better tolerated by patients that EMG has largely become a research tool \[[@B8]\]. Although no clear correlation has been found between manometric neurophysiological testing and clinical symptomatology in patients with idiopathic fecal incontinence, performing these tests before surgery may predict long-term outcome \[[@B7][@B9]\]. Anorectal investigation has revealed a large group of parous women with occult sphincter trauma that may have a clinical impact as these women get older \[[@B5][@B9]\]. Newer electrophysiological tests and improved AES would more effectively select patients for appropriate treatment and, thus, lead to better outcome.

ELECTROPHYSIOLOGY
=================

The impetus to develop electrophysiological techniques for the purpose of investigating sphincter function in order to determine the cause of fecal incontinence came from the work of Parks and Swash \[[@B10]\]. They identified histological changes in the anal sphincter, showing evidence of denervation of the muscle. Standard electromyographic and nerve conduction studies used elsewhere in the body were adapted to study the anal sphincter and other pelvic floor muscles. These tests have provided a detailed understanding of the pathophysiology of incontinence and several other conditions affecting the pelvic floor muscles. In patients with fecal incontinence, once the anal sphincter has been shown manometrically to be weak, anorectal physiological studies are used increasingly by coloproctologists to determine the cause for the muscle weakness \[[@B6][@B9][@B10]\].

Pudendal nerve terminal motor latency
-------------------------------------

In 1984, Kiff and Swash \[[@B11]\] demonstrated that trans-stimulation of the pudendal nerves induced ejaculation in patients with paraplegia. This is because they carry the parasympathetic component for genital erection (pelvic splanchnic nerve -- S 2, 3, 4 roots), as well \[[@B12]\]. This initiated the assessment tests of motor conduction in the distal part of the pudendal nerve, which is most vulnerable to injury \[[@B13]\]. Weakness of the external anal sphincter due to pudendal nerve damage may occur in 2 ways -- a direct stretch-induced injury during vaginal delivery and chronic straining at stool. In addition, damage to the pelvic nerves causing perineal descent, in turn, leads to pudendal nerve stretch \[[@B14]\]. Thus, abnormal pudendal nerve motor latency (PNML) occurs in patients with neurogenic fecal incontinence \[[@B1]\]. Stretch-induced injury arises because of the anatomy of the pudendal nerves. The position of the nerves is fixed as they pass behind the ischial spine, but distal to this point, the nerves are able to move freely and may be damaged if excessive floor descent occurs. In normal subjects, the pelvic floor descends up to 2 cm during straining down, but a descent of up to 3 cm is abnormal. Perineal descent of this magnitude will produce a stretch of the pudendal nerve of 20% above its usual length, and because a stretch of only 12% produces nerve damage, that abnormal perineal descent is postulated to cause pudendal nerve damage \[[@B15][@B16]\].

Studies have shown a linear correlation and a significant relationship between perineal descent and pudendal latency \[[@B11][@B13]\]. Abnormal perineal descent and nerve damage are caused by chronic straining at stool and difficult vaginal delivery \[[@B1][@B4][@B5][@B6][@B13]\]. Repeated neuropraxia in the former over a long period of time leads to permanent nerve damage \[[@B16][@B17]\]. Abnormal pudendal latency is also found in patients with combined fecal and urinary incontinence \[[@B13][@B18]\], incontinence persisting after rectopexy for prolapse \[[@B19]\], chronic constipation \[[@B20]\], hemorrhoids \[[@B21]\], symptomatic uterovaginal prolapse \[[@B22]\], and solitary rectal ulcer syndrome \[[@B23]\]. Pudendal latencies should be measured bilaterally because nerve damage is sometimes asymmetric \[[@B11]\]. Normal pudendal latencies are found in patients with diabetes and normal continence, although prolonged pudendal latencies have been found in patients with diabetics with or without incontinence \[[@B24]\]. Pudendal latency increases with age in normal subjects, and it is higher in men than women, but no sex differences have been found in patients with constipation \[[@B16]\].

Pudendal neuropathy is not a predictor of surgical intervention for fecal incontinence, but independent predictors include the presence of a prolapse, a functional sphincter length \<1 cm, an external anal sphincter defect, and a Cleveland Clinic Incontinence Score ≥10 ([Table 2](#T2){ref-type="table"}) \[[@B25]\]. In clinical assessments, pudendal nerve studies are of particular value in patients with fecal incontinence, but not in those with solitary rectal ulcer syndrome, hemorrhoids or the complexity of obstructive defecation syndrome as many of the associated problems or pathologies may not be immediately apparent. In addition, the PNML is operator dependent and has a poor correlation with clinical symptoms and histological findings. The investigation only examines the fastest conducting fibers of the pudendal nerve, so the PNML can still be normal even in the presence of abnormal sphincter innervation \[[@B11]\]. Pudendal nerve testing may not, therefore, contribute to surgical decision making in patients with fecal incontinence \[[@B25]\]. The American Gastroenterology Association does not, therefore, recommend the use of pudendal nerve testing for the evaluation of patients with fecal incontinence \[[@B26]\].

The perineal branch of the pudendal nerve innervates the striated urethral sphincter muscle, and the course of the perineal nerve to the urethral sphincter is longer than that of the inferior rectal nerve to the external anal sphincter. Thus, the perineal nerve latency is longer than the pudendal latency. The perineal nerve latency is measured in the same way as the pudendal latency by using an intrarectal nerve-stimulating device, but the muscle response is recorded in the urethral sphincter by using a bipolar ring electrode mounted on a urethral Foley catheter \[[@B18]\]. Perineal nerve latency is a useful measure of denervation in patients with urinary stress incontinence, although clinicians rely mainly on the results of urodynamic studies. The perineal motor latency is greater in patients with double incontinence than it is in those with fecal or urinary incontinence alone \[[@B18]\]. However, because perineal latency is more difficult and time consuming to measure than pudendal latency, and has the added risk of introducing urinary sepsis, perineal latency has remained a research tool in most laboratories.

Spinal motor latency
--------------------

Transcutaneous stimulation of the sacral motor nerve roots provides further information on the innervation of the pelvic floor. In patients with neuropathic fecal and urinary incontinence, damage to the external anal sphincter and to the puborectalis and the levator ani muscles has been shown to occur \[[@B27][@B28]\]. Because the nerve supply to the puborectalis and levators is almost entirely from direct pelvic nerves (S3, 4), it follows that these nerves have been injured. The mechanism has not been clearly identified but it has been assumed that there are not subject to the same stretch injury as the pudendal nerves distal to the ischial spines. In parous women, direct pressure of the fetal head on the nerves during the second stage of labor may cause nerve damage \[[@B29]\]. Other proximal nerve lesions are considered as supranuclear or infranuclear, depending on their relation to the Onuf nucleus ([Table 1](#T1){ref-type="table"}) \[[@B30]\]. Infranuclear (lower motor neurone) lesions result from damage to the sacral nerve roots in the pelvis or within the cauda equina. Conditions in the pelvis may include primary tumors or cysts whereas cauda equina disease may result from sacral spondylosis, disc prolapse, trauma, or intraspinal neoplasms.

Transcutaneous stimulation of the cauda equina over the lumbar spine measures conduction along the cauda equina, the sacral plexus, and the branches from the plexus. Thus, injury manifested as a slowing of conduction may be regarded as occurring in (1) the cauda equina; (2) the pelvis, affecting the sacral plexus and the direct branches innervating the levator ani (S4); or (3) the pudendal nerves distal to the ischial spines (S2, 3, 4). The evoked response can be recorded using standard EMG needles inserted at three sites: the puborectalis, external sphincter and the urethral sphincter \[[@B31]\]. If a stretch-induced injury to the pudendal nerves exists, then the conduction time from the spinal cord (L1 stimulation) to the external sphincter (spinal latency) will be prolonged as will the pudendal nerve terminal motor latency. If the injury is above the level of the ischial spine, then the spinal latency (L1 stimulation) will be prolonged, and the pudendal latency from L4 stimulation will be normal.

A spinal latency ratio (SLR) is calculated to determine whether the abnormality lies within the cauda equina or beyond that site. If the abnormality lies distal to the caudal equina, then the latency from both sides will be prolonged, and the SLR is constant. If the abnormality is within the cauda equina, then only the L1 latency will be prolonged as the SLR will be increased \[[@B30]\]. Thus, by comparing the latency times between the 2 levels, the latency of the motor component of the cauda equina can be assessed. Up to 23% of patients with idiopathic fecal incontinence will have cauda equina delay \[[@B32][@B33]\]. Normal values of the spinal latency and the SLR are given in [Table 3](#T3){ref-type="table"} \[[@B18]\].

THE CONTINENCE FACTORS
======================

The continence factors are the involuntary, smooth, internal anal sphincter (passive continence) controlled by the parasympathetic and sympathetic nervous system; the voluntary, striated, external anal sphincter (active : urge continence) controlled by the pudendal nerve (S2, 3, 4); the ano-rectal angle produced by the striated puborectalis sling of the pelvic floor (lower edge of the levator ani \[S4\]); the anal cushions and mucosal folds; and the lateral abdominal pressure on the upper anterior part of the lower rectum. The rectum is supplied by both sympathetic and parasympathetic nerves. The sympathetic nerves from the superior hypogastric plexus contract the smooth muscle sphincters, relax the bowel, and transmit pain whereas the parasympathetic nerves in the pelvis splanchnic nerve (S2, 3, 4) of the inferior hypogastric plexus relax smooth muscle sphincters, contract the bowel, and transmit the feeling of fullness ([Fig. 1](#F1){ref-type="fig"}) \[[@B12]\]. The lower third of the rectum is normally empty except during defecation when it distends into the ischioanal fossa, as necessary. The upper two-thirds is distensible into the abdominal cavity and stores feces only in constipation. Normally, feces are stored in the colon above and only enters the rectum just before defecation during the mass movement of feces from above.

TREATMENT OF FECAL INCONTINENCE
===============================

The treatment of fecal incontinence depends on its etiology \[[@B34]\]. The majority of patients who have a specific sphincter defect following obstetric trauma, which has been identified by using endoanal ultrasound, will benefit from anterior sphincter repair in the short term. If the primary problem is a specific sphincter defect, an anterior sphincter repair with levatorplasty is preferred \[[@B35][@B36][@B37][@B38][@B39][@B40]\]. However, many of these patients will have a degree of coexisting neuropathic damage to the pelvic floor, particularly if they have undergone multiple vaginal deliveries \[[@B38]\]. Although the presence of neuropathic damage in these patients does not alter the initial surgical management \[[@B25]\], it does influence the prognosis as seen in the poor long-term benefit (40%) from post anal repair or a total pelvic floor repair except for those with anatomical defects such as a rectocele or an abnormal perineal descent \[[@B39][@B40]\]. The etiology of the progression of the pudendal nerve damage over time is not known. However, since the advent of sacral nerve stimulation (SNS), total pelvic floor repair has become obsolete. Those in whom the incontinence is neurological in origin may benefit from a conservative approach initially \[[@B7]\].

Conservative treatment
----------------------

Following careful assessment and investigation, the majority of patients may benefit from conservative treatment. Patients with severe neuropathic incontinence are best treated by using intensive conservative management with control of stool consistency and with physiotherapy or pelvic floor retraining (biofeedback) before surgical treatment is considered \[[@B41]\]. Surgical options are limited as many of these patients do not have any sphincter defect amenable to repair, and sphincter procedures, postanal repair, and total pelvic floor repair have proven ineffective \[[@B5][@B42]\].

Biofeedback
-----------

Biofeedback is particularly useful in patients who primarily have a sensory problem in the anal canal leading to insensible loss of feces. Patients are trained using either electromyographic or manometric feedback to improve the strength of their anal sphincters and if this is coupled with an intrarectal balloon, their rectal sensory awareness may be improved \[[@B43]\]. More specific physiotherapy using either interferential treatment of the pelvic floor and, in particular, trophic stimulation via an anal plug electrode, which uses electrical impulses designed to mimic the train of signals along the pudendal nerve, can be extremely successful. The precise role of electrical stimulation of the pelvic floor is unclear, but the results are almost equivalent to those obtained by using postanal repair \[[@B44][@B45]\]. Biofeedback training can lead to improvements in 70% of the patients \[[@B42]\] and in patients with structural defects of the anal sphincters \[[@B46][@B47][@B48]\].

Sacral nerve stimulation
------------------------

SNS is a promising innovation that will probably become the treatment of choice for neuropathic fecal incontinence and following failed sphincter repair. As SNS has been used in the treatment of urinary incontinence, a similar technique has been utilized for fecal incontinence with promising results \[[@B49][@B50]\]. For patients in whom the primary etiology appears to be neurogenic and in whom preoperative investigations have failed to reveal a sphincter defect, a trial of SNS is justified \[[@B50][@B51]\]. SNS works by electrical stimulation of the sacral (S2--S4) nerve roots, thereby producing a combination of anal sphincter augmentation and modulation of spinal/supraspinal pathways. It benefits from a 2-stage procedure, which enables the patient to assess acceptability, and the clinician to evaluate efficacy prior to permanent implantation. It entails an initial trial stimulation. A percutaneous wire is inserted under general or local anesthesia into the second, third, or fourth sacral foramen. Successful positioning is indicated by contraction of the pelvic floor and flexion of the ipsilateral great toe. The wire is connected to an external stimulator, and the patient is asked to keep a bowel diary for the 2 to 3 weeks of temporary stimulation, which allows the clinician to quantify the degree of response. A positive response is defined as a reduction in incontinence episodes or an incontinence score of ≥50% during the stimulation period \[[@B52]\]. If successful, a permanent indwelling stimulator can be inserted. A permanent tined electrode is implanted via a percutaneous approach. The implanted pulse generator is connected and inserted into a subcutaneous pocket created in the ipsilateral buttock, and the settings can be altered transcutaneously by the clinician or patient \[[@B51]\].

The trial stimulation is associated with a very low level of complications and with a complication rate of 5%--10% for insertion of a permanent implant \[[@B53]\]. Initial reports have suggested improvements in continence in approximately 70%--80% of patients who had been permanently implanted \[[@B54]\]. The technique appears to benefit patients who have an intact anal sphincter on ultrasound and some preservation of pudendal nerve function. Early studies have demonstrated the benefit of sacral neuromodulation in patients with spinal cord injuries \[[@B55]\], and an intact anal sphincter would also appear not to be necessary for success with SNS in patients with fecal incontinence \[[@B56]\]. More recent studies have demonstrated that in the medium term, SNS is an effective option for patients with neuropathic incontinence who have failed conservative treatment and for whom the only viable alternative option would be a stoma \[[@B57][@B58]\]. For young patients who have severe sphincter injuries, a failed sphincter repair, or insufficient residual sphincter, consideration should be given to either SNS or some form of sphincter augmentation or artificial bowel sphincter \[[@B59][@B60]\].

Treatment strategies for adult FI are summarized in the National Institute for Health and Care Excellence 2007 guidance, which supports the use of SNS for the treatment of adult FI refractory to conservative measures \[[@B7]\]. SNS has been widely adopted and is currently considered the standard of care for adults with moderate to severe fecal incontinence \[[@B60][@B61][@B62][@B63][@B64][@B65][@B66][@B67][@B68][@B69]\]. Although the short-term efficacy of SNS is good, with 70%--80% of patients experiencing symptom improvement, 25% of patients suffer loss of efficacy with time, and a further 2%--5% suffer irresolvable complications and undergo explantation \[[@B65][@B66]\]. Although published longer-term studies with larger numbers of patients and reasonable follow-up have confirmed the effectiveness of SNS, from a decision-to-treat perspective, the long-term efficacy is around 50% \[[@B67][@B68][@B69][@B70][@B71]\]. However, SNS is very costly \[[@B3]\].

Posterior tibial nerve stimulation
----------------------------------

Posterior tibial nerve stimulation (PTNS) is a noninvasive neuromodulation method used for the treatment of patients with fecal incontinence. The PTN contains sensory, motor, and autonomic fibers that emerge from L4 and L5, as well as S1 to S3 \[[@B34][@B60]\]. PTNS is not as effective as SNS, but is less expensive and complicated \[[@B61][@B62]\]. Afferent impulses (200 msec, 10 mA, 10 Hz current) to both tibialis posterior nerves emanate from electrodes placed above the medial malleolus. The treatment utilizes 20 PTNS sessions per month. It is usually used after failed conservative and behavioral interventions \[[@B63][@B64]\]. Because frequent treatment sessions are required, it may be more suitable as an in-house procedure for elderly patients in a nursing home.

Sphincter augmentation
----------------------

Sphincter augmentation procedures can be used for patients who are not suitable for direct repair or in whom a previous repair has failed. Various muscles, including the gluteus maximus, sartorius, adductor lunges and, most commonly, gracilis, have been used in sphincter augmentation. The advantage of the gracilis muscle is that it is the most superficial muscle in the medial aspect of the thigh and is approximately the right size. In addition, its blood and nerve supply enter proximally. Thus, a distal division of the muscle does not compromise the blood supply. The operation has been superseded by the electrically stimulated gracilis neosphincter, which is a better physiological replacement (with the resting tone of the prepondering slow switch fibres) of the external sphincter \[[@B72][@B73][@B74][@B75]\]. The techniques have evolved and now use intramuscular electrodes rather than direct stimulation of the nerve to the gracilis, which is associated with significantly greater mechanical problems, such as perineural fibrosis and electrode migration, that require revisional surgery \[[@B76][@B77]\].

Neosphincter
------------

The artificial bowel sphincter for the treatment of patients with fecal incontinence has not proved to be as successful as the artificial sphincter for the treatment of patients with urinary incontinence has. It was associated with significant complications in a multicenter cohort study: 45% of patients required revisional sursurgery, and 37% required removal of the device. In those patients who retained their device, continence was satisfactory, being over 80% \[[@B78]\]. In centers at which specialists have particular experience in the technique, the artificial bowel sphincter appears to be a valuable alternative for patients, but a very high incidence of infective complications has been reported \[[@B79]\]. In the elderly, who have poor prognostic factors, not attempting reconstructive surgery, but offering a permanent colostomy, which may well restore quality of life in the least traumatic way, may be in the patient\'s best interest \[[@B67]\].

Magnetic sphincter
------------------

The FENIX magnetic sphincter augmentation (MSA) device is a novel continence device consisting of a flexible band of interlinked titanium beads with magnetic cores that is placed around the anal canal to augment anal sphincter tone through passive attraction of the beads. Preliminary studies suggest that the FENIX MSA is safe, but efficacy data are limited. A rigorous evaluation is required prior to widespread adoption. The SaFaRI trial is a randomized, controlled, unblinded trial that will investigate the use of the FENIX MSA, as compared to SNS, for the treatment of adults with fecal incontinence resistant to conservative management \[[@B80]\]. The primary endpoint is success, as defined by device in use and ≥50% improvement in the Cleveland Clinic Incontinence Score at 18 months postrandomization. Secondary endpoints include complications, quality of life, and cost effectiveness. SaFaRI will rigorously evaluate the new technology (FENIX MSA) for the treatment of adults with fecal incontinence and for its safe and controlled introduction into current clinical practice.

CONCLUSION
==========

Although the mechanism of action of SNS remains unknown, it appears to benefit the majority of patients with fecal incontinence, particularly those with neuropathic damage to the pelvic floor. As prevention of obstetric trauma altogether is unlikely, the use of SNS will increase in the future. The indications for stimulated neosphincter formation or a magnetic sphincter are expanding, but the use of the artificial bowel sphincter is speculative. Newer electrophysiological tests and improved AES would guide clinical decision making and render a better outcome.
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###### Etiology of fecal continence \[[@B59]\]
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###### Cleveland Clinic Scoring system for assessment of fecal incontinence \[[@B59]\]
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Rarely, less than once a month; Sometimes, more than once a month, but lees than once a week; Usually, more than once a week, but less than once a day; Always, more than once a day.

###### Transcutaneous spinal stimulation latencies in normal subjects \[[@B23]\]
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Values are presented as mean ± standard deviation.

SLR, spinal latency ratio.
